BESTARA Trademark

Trademark Overview

On Friday, January 15, 2010, a trademark application was filed for BESTARA with the United States Patent and Trademark Office. The USPTO has given the BESTARA trademark a serial number of 77913019. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 26, 2013. This trademark is owned by Glaxo Group Limited. The BESTARA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
bestara

General Information

Serial Number77913019
Word MarkBESTARA
Filing DateFriday, January 15, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 26, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 21, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, August 26, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 26, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 23, 2013EXTENSION 5 GRANTED
Sunday, January 20, 2013EXTENSION 5 FILED
Sunday, January 20, 2013TEAS EXTENSION RECEIVED
Friday, August 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 9, 2012EXTENSION 4 GRANTED
Tuesday, July 24, 2012EXTENSION 4 FILED
Tuesday, July 24, 2012TEAS EXTENSION RECEIVED
Friday, January 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2012EXTENSION 3 GRANTED
Tuesday, January 17, 2012EXTENSION 3 FILED
Tuesday, January 17, 2012TEAS EXTENSION RECEIVED
Tuesday, July 12, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 11, 2011EXTENSION 2 GRANTED
Thursday, July 7, 2011EXTENSION 2 FILED
Thursday, July 7, 2011TEAS EXTENSION RECEIVED
Tuesday, January 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2011EXTENSION 1 GRANTED
Wednesday, December 8, 2010EXTENSION 1 FILED
Monday, January 10, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 8, 2010TEAS EXTENSION RECEIVED
Tuesday, July 27, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2010PUBLISHED FOR OPPOSITION
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 28, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 28, 2010ASSIGNED TO LIE
Thursday, April 15, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 12, 2010ASSIGNED TO EXAMINER
Thursday, January 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 19, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

bestara pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic